<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>project 2</title>
    <link rel="stylesheet" href="../styles/style.css">
</head>

<body>
    <header class="header">
        <h1>
            <p>
                Solensia is the once-monthly, vet-administered monoclonal antibody therapy for the control of pain of feline osteoarthritis(OA)
            </p>
        </h1>
    </header>
    <section class="section">
        <div class="wraper">
            <div class="list-item">
                <ul>
                    <li>77% of cost owners reported improvement in signs of pain after their cats were treated with Solensia for 3 months in a study.
                    </li>
                    <li>Controls the pain of OA in cats, helping to improve their mobility, comfort and well-being.
                    </li>
                    <li>Solensia was found to be well tolerated in filed studies that included cats identified as IRIS stage 1 to 2.
                    </li>
                </ul>
            </div>
            <div class="image-item">
                <img src="https://publicisgroupe-my.sharepoint.com/personal/madr_publicisgroupe_net/Documents/Microsoft%20Teams%20Chat%20Files/injectable-solution.svg" alt="solution image">
                <a href="#"><button class="button" type="submit">Product Details Page</button></a>
            </div>
        </div>
    </section>
    <hr class="hr-line">
    <footer class="footer">
        <p class="footer-item">
            Based on total improvement of pain scores after three monthly doses using a pet owner assesment Total N = 131 of 267 treated cats were identified as IRIS stage 1 to 2.
        </p>
    </footer>
</body>

</html>